BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11431552)

  • 1. Signal transduction: signaling specificity- a complex affair.
    Weston CR; Davis RJ
    Science; 2001 Jun; 292(5526):2439-40. PubMed ID: 11431552
    [No Abstract]   [Full Text] [Related]  

  • 2. Missing links in GSK3 regulation.
    Dominguez I; Green JB
    Dev Biol; 2001 Jul; 235(2):303-13. PubMed ID: 11437438
    [No Abstract]   [Full Text] [Related]  

  • 3. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of the phosphorylation of beta-catenin at the GSK-3 priming site Ser45.
    Hagen T; Vidal-Puig A
    Biochem Biophys Res Commun; 2002 Jun; 294(2):324-8. PubMed ID: 12051714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. beta-catenin and its multiple partners: promiscuity explained.
    Shapiro L
    Nat Struct Biol; 2001 Jun; 8(6):484-7. PubMed ID: 11373611
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
    Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
    Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
    Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Akt participation in the Wnt signaling pathway through Dishevelled.
    Fukumoto S; Hsieh CM; Maemura K; Layne MD; Yet SF; Lee KH; Matsui T; Rosenzweig A; Taylor WG; Rubin JS; Perrella MA; Lee ME
    J Biol Chem; 2001 May; 276(20):17479-83. PubMed ID: 11278246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
    Willert K; Shibamoto S; Nusse R
    Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
    Yuan H; Mao J; Li L; Wu D
    J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-catenin: its discovery as a cadherin-associated protein and its function as a transcription activator].
    Ozawa M
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(3):197-207. PubMed ID: 11244716
    [No Abstract]   [Full Text] [Related]  

  • 12. Wnt signaling and cancer.
    Polakis P
    Genes Dev; 2000 Aug; 14(15):1837-51. PubMed ID: 10921899
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3: new thoughts on an old enzyme.
    Ferkey DM; Kimelman D
    Dev Biol; 2000 Sep; 225(2):471-9. PubMed ID: 10985864
    [No Abstract]   [Full Text] [Related]  

  • 15. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
    Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X
    Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure of phosphorylated GSK-3beta complexed with a peptide, FRATtide, that inhibits beta-catenin phosphorylation.
    Bax B; Carter PS; Lewis C; Guy AR; Bridges A; Tanner R; Pettman G; Mannix C; Culbert AA; Brown MJ; Smith DG; Reith AD
    Structure; 2001 Dec; 9(12):1143-52. PubMed ID: 11738041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of GSK-3: a cellular multiprocessor.
    Harwood AJ
    Cell; 2001 Jun; 105(7):821-4. PubMed ID: 11439177
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin.
    Monick MM; Carter AB; Robeff PK; Flaherty DM; Peterson MW; Hunninghake GW
    J Immunol; 2001 Apr; 166(7):4713-20. PubMed ID: 11254732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wnt signalling gets XEEKy.
    Clements WK; Kimelman D
    Nat Cell Biol; 2003 Oct; 5(10):861-3. PubMed ID: 14523399
    [No Abstract]   [Full Text] [Related]  

  • 20. Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth.
    Haq S; Michael A; Andreucci M; Bhattacharya K; Dotto P; Walters B; Woodgett J; Kilter H; Force T
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4610-5. PubMed ID: 12668767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.